Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".

Marasca, Claudio

Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes". [electronic resource] - Journal of the American Academy of Dermatology 05 2023 - e269 p. digital

Publication Type: Observational Study; Letter; Comment

1097-6787

10.1016/j.jaad.2019.02.066 doi


Humans
Clindamycin--adverse effects
Rifampin--therapeutic use
Hidradenitis Suppurativa--drug therapy
Prevalence
Anti-Bacterial Agents--therapeutic use